Palliative Care Research Cooperative Group (PCRC): Investigator Development Center

姑息治疗研究合作小组 (PCRC)：研究者发展中心

• 批准号: 10207786
• 负责人: Christine S Ritchie
• 金额: $ 19.87万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-28 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10207786
• 关键词: Active Learning; Area; Caregiver research; Caring; Childhood; Clinical; Clinical Research; Clinical Trials; Collaborations; Committee Members; Communication; Communities; Competence; Conduct Clinical Trials; Consult; Data; Development; Economically Deprived Population; Educational Curriculum; Educational Status; Ethics; Fostering; Funding; Future; Goals; Individual; Informatics; Instruction; International; Leadership; Measurement; Mentors; Mentorship; Methodological Studies; Methodology; Multi-Institutional Clinical Trial; Multi-site clinical study; Palliative Care; Pilot Projects; Play; Population; Population Heterogeneity; Productivity; Research; Research Activity; Research Personnel; Research Support; Research Training; Resources; Role; Science; Site; Structure; Training; Translational Research; Underrepresented Minority; Vulnerable Populations; Work; advanced disease; care delivery; clinical research site; end of life; evidence base; experience; investigator training; medical specialties; member; multiple chronic conditions; next generation; programs; recruit; research and development; research data dissemination; skills; special interest group; statistics; tool; webinar

PROJECT SUMMARY/ABSTRACT The primary goals of this U2C application are to increase the productivity and impact of the Palliative Care Research Cooperative Group (PCRC), through facilitating the conduct of high-quality, effective clinical research, and expanding the number and expertise of palliative care researchers to conduct multi-site clinical trials. In pursuit of these overall goals and objectives, the Investigator Development Center (IDC), one of two Centers within the PCRC, strives to equip investigators in EOLPC research with the suite of tools necessary to create a robust evidence base for the care of individuals with serious, advanced illness. The specific aims of the IDC are: (1) to enhance the capacity of investigators at all stages to successfully conduct multi-site clinical research in the area of EOLPC science by (a) supporting research training and development through experiential and didactic instruction, (b) providing structured mentoring focused on principles of palliative care, methodological issues commonly encountered in EOLPC research, and translational research approaches, (c) administering the PCRC Pilot Projects Program, (d) providing clinical trials training and sustaining investigator engagement through Clinical Trials Intensives, and (e) providing specific training on the recruitment and retention of diverse and vulnerable populations; (2) to develop, evaluate and refine resources for EOLPC investigators at all levels in the conduct of clinical trials according to current clinical, ethical and regulatory standards by (a) collaborating with other PCRC Cores to enhance rigor among studies that consult the PCRC and promote consistent and coordinated investigator guidance from the Cores, (b) partnering with investigators from diverse disciplinary specialties and with relevant expertise to develop competencies for the conduct of high-quality, multi-site clinical studies in EOLPC, and (c) collaborating with national and international organizations on EOLPC research training and dissemination; (3) to promote research leadership by (a) enhancing mentoring skills through tailored, longitudinal mentor training, (b) partnering with the Project Coordinating Center (PCC) to equip PCRC members to serve as effective committee members and chairs, and (c) training investigators to plan research, manage teams, and execute projects; and (4) to build a research community by (a) expanding PCRC special interest groups and other research collaboration opportunities, and (b) regularly evaluating and tailoring IDC programs to meet the evolving needs of PCRC constituents. By achieving these aims, the IDC will increase the capacity of the EOLPC workforce to effectively conduct multi- site studies.

项目摘要/摘要 该U2C应用的主要目标是提高姑息治疗的生产率和影响 研究合作小组（PCRC），通过促进高质量，有效临床的行为 研究，并扩大姑息治疗研究人员的数量和专业知识，以进行多站点临床 试验。为了追求这些总体目标，研究者开发中心（IDC），两个 PCRC中的中心，努力为调查人员提供EOLPC研究中的调查人员，并配备必要的工具 为患有严重，晚期疾病的人的照顾建立一个强大的证据基础。具体目的 IDC是：（1）在各个阶段增强研究人员成功进行多站点临床的能力 （a）通过（a）支持研究培训和发展的研究 经验和教学教学，（b）提供结构化指导，重点是姑息治疗原则， EOLPC研究和翻译研究方法中通常遇到的方法论问题，（c） 管理PCRC试点项目计划，（d）提供临床试验培训和维持研究人员 通过临床试验强化参与，（e）提供有关招聘和的特定培训 保留多样化和脆弱的人群； （2）为EOLPC开发，评估和完善资源 根据当前的临床，道德和调节性 （a）与其他PCRC核心合作的标准，以增强咨询PCRC的研究中的严格性 并促进核心的一致和协调的研究者指导，（b）与研究人员合作 来自各种纪律专业，并具有相关专业知识，以发展能力 EOLPC的高质量，多站点临床研究，以及（c）与国家和国际合作 EOLPC研究培训和传播的组织； （3）促进（a）的研究领导 通过量身定制的纵向导师培训来提高指导技能，（b）与该项目合作 协调中心（PCC）为PCRC成员提供有效的委员会成员和主席，并 （c）培训调查人员计划研究，管理团队和执行项目； （4）建立研究 （a）扩大PCRC特殊利益小组和其他研究合作机会的社区，以及 （b）定期评估和调整IDC计划，以满足PCRC成分不断发展的需求。经过 实现这些目标，IDC将增加EOLPC劳动力的能力，以有效地进行多种多样 现场研究。